BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37659577)

  • 1. The effect of progesterone supplementation in women with threatened miscarriage on fetal fraction in non-invasive prenatal testing: A matched case-control study.
    İleri A; Yıldırım Karaca S; İleri H; Karaca İ; Gölbaşı H; Özer M; Budak A; Kutbay YB; Koç A; Özeren M
    J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102662. PubMed ID: 37659577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
    Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
    Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of exogenous oral micronized progesterone on first trimester aneuploidy screening markers in women with threatened miscarriage: a matched case control study.
    Karaca I; Erdoğan ŞV; Doğan K; Alay I; Ince O; Yıldırım Karaca S; Comba C; Bahceci E; Erdoğan A; Ozturk E; Ekin M
    J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1224-1229. PubMed ID: 32456488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial.
    McLindon LA; James G; Beckmann MM; Bertolone J; Mahomed K; Vane M; Baker T; Gleed M; Grey S; Tettamanzi L; Mol BWJ; Li W
    Hum Reprod; 2023 Apr; 38(4):560-568. PubMed ID: 36806843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive role of sTWEAK levels in pregnant women with first-trimester vaginal bleeding
    Kasap B; Özel Türkçü Ü; Akbaba E; Sarıyıldız B; Küçük M; Turhan NÖ; Öner G; Özcan A
    J Matern Fetal Neonatal Med; 2018 Jul; 31(13):1715-1719. PubMed ID: 28462593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies.
    Talbot AL; Ambye L; Hartwig TS; Werge L; Sørensen S; Stormlund S; Prætorius L; Jørgensen HL; Pinborg A; Jørgensen FS
    Hum Reprod; 2020 Jun; 35(6):1267-1275. PubMed ID: 32539141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
    Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
    Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
    Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
    Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability.
    al-Sebai MA; Kingsland CR; Diver M; Hipkin L; McFadyen IR
    Br J Obstet Gynaecol; 1995 May; 102(5):364-9. PubMed ID: 7612529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
    Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation of serum estradiol and progesterone levels with abortive anticipation in pregnant women with fetal irritability and vaginal bleeding].
    Lou YY; Fu P; Liu XR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1153-6. PubMed ID: 21275165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic pregnancy loss and recurrent miscarriage.
    Devall AJ; Coomarasamy A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():30-39. PubMed ID: 32978069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can single progesterone concentration predict miscarriage in early pregnant women with threatened miscarriage: a systematic review and meta-analysis.
    Gong Y; Jiang T; Sun Y; Wu GL; Han BW; Shi Y; Guan S; Li J
    BMC Pregnancy Childbirth; 2024 Feb; 24(1):133. PubMed ID: 38350926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of machine learning tools to predict threatened miscarriage in the first trimester based on AEA, progesterone and β-hCG in China: a multicentre, observational, case-control study.
    Huang J; Lv P; Lian Y; Zhang M; Ge X; Li S; Pan Y; Zhao J; Xu Y; Tang H; Li N; Zhang Z
    BMC Pregnancy Childbirth; 2022 Sep; 22(1):697. PubMed ID: 36085038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threatened miscarriage in the first trimester and retrochorial hematomas: sonographic evaluation and significance.
    Soldo V; Cutura N; Zamurovic M
    Clin Exp Obstet Gynecol; 2013; 40(4):548-50. PubMed ID: 24597253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-pregnancy events and subsequent antenatal, delivery and neonatal outcomes: prospective cohort study.
    Al-Memar M; Vaulet T; Fourie H; Nikolic G; Bobdiwala S; Saso S; Farren J; Pipi M; Van Calster B; de Moor B; Stalder C; Bennett P; Timmerman D; Bourne T
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):530-537. PubMed ID: 30887596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.
    Lee HJ; Park TC; Kim JH; Norwitz E; Lee B
    Biomed Res Int; 2017; 2017():3616875. PubMed ID: 29392134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does progesterone therapy increase nuchal translucency in women with threatened miscarriage?
    Keçecioğlu M; Tokmak A; Keçecioğlu TS; Akselim B; Karakaya BK; Taşçı Y
    Ginekol Pol; 2016; 87(5):390-4. PubMed ID: 27304657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: clinical evidences.
    Costantino M; Guaraldi C; Costantino D
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1656-63. PubMed ID: 27160142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same-day confirmation of intrauterine pregnancy failure in women with first- and early second-trimester bleeding.
    Mor A; Tal R; Haberman S; Kalgi B; Nasab SH; Minkoff H
    Fertil Steril; 2018 Jun; 109(6):1060-1064. PubMed ID: 29935643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.